Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 1b/2, Open-Label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic B… Recruiting

2022-503114-23-00 Breast Cancer 3 2023-12-19
Tucatinib in combination with Oral Etoposide (VP16) and Trastuzumab in Patients with metastatic HER2+ Breast cancer (TUC-TOC) Recruiting

2022-500743-20-00 Metastatic HER2+ Breast cancer 4 2023-12-19
Neo-adjuvant pembroliuzmab as an alternative treatment for MMRd uterine cancer Recruiting

2024-516736-10-00 Mismatch repair deficient endometrial cancer / uterine 4 2023-12-18
LSTA1 for subjects with newly diagnosed Glioblastoma Multiforme when added to standard of care (temozolomide) versus temozolomide Recruiting

2023-506813-23-00 Glioblastoma Multiforme 4 2023-12-18
Imaging multiple myeloma patients in the REMNANT study with Fluciclovine PET/CT (FLUCIPET) Recruiting

2024-517095-38-00 multiple myeloma 10 2023-12-18
A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in … Recruiting

2022-501941-63-00 Multiple myeloma 7 2023-12-13
Neoadjuvant trastuzumab, pertuzumab and tucatinib without chemotherapy in HER2-positive breast cancer: the TRAIN-4 study Recruiting

2024-518192-61-00 Breast cancer 9 2023-12-08
SGM-T1: SGM-101 tumor targeted fluorescence endoscopy in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia Recruiting

2024-510769-41-00 Early rectal cancer 4 2023-12-07
A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of… Recruiting

2024-510767-30-00 Brain metastases 4 2023-12-04
Fully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinically significant prostate cancer Recruiting

2024-512859-21-00 Patients with clinical suspicion of clinically relevant 4 2023-12-04
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors Recruiting

2022-502456-31-00 Advanced or metastatic solid tumors 1 2023-11-30
Study aiming to assess the clinical impact of dostarlimab on occurrence of second primary cancer in patients with cured primary cancer Recruiting

2022-501316-34-00 Patient cured from a primary cancer and at risk of 2nd 4 2023-11-27
ALEPRO: abemaciclib and letrozole in estrogen receptor positive rare ovarian cancer Recruiting

2023-503533-21-00 Low-grade serous ovarian cancer 4 2023-11-21
A Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory… Recruiting

2023-503206-37-00 Mantle Cell Lymphoma (MCL) 5 2023-11-20
Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsy Recruiting

2024-519351-28-00 Patients with melanoma of the head/neck or the upper pa 4 2023-11-15
International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies … Recruiting

2022-501869-41-00 Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic 9 2023-11-14
FOENIX-CCA4 Recruiting

2023-503665-39-00 Advanced cholangiocarcinoma 4 2023-11-14
FIPO23 Phase I/II, multi center, Open Label, First-in-human, Dose Escalation and Expansion study to investigate the Safety, Pharmacokinetics… Recruiting

2023-505266-29-00 Advanced or metastatic solid tumors 7 2023-11-14
A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics o… Recruiting

2022-502193-16-00 Chronic lymphocytic leukemia, Multiple Myeloma and Non- 5 2023-11-14
Indocyanine green to assess vascularity of ileal conduit anastomosis and regulate ureteral resection margins during pelvic exenteration for … Recruiting

2024-518783-13-00 Patients with gynecological cancers undergoing pelvic e 4 2023-11-09
Performance and prognostic value of 68Ga-FAPI PET/CT in non-small cell lung cancer (NSCLC) Recruiting

2023-503985-21-00 Non small cell lung cancer 3 2023-11-07
LiBRA – Lithium treatment to prevent cognitive impairment after brain radiotherapy. Recruiting

2023-504071-24-00 Brain tumor 4 2023-11-07
A study to examine the safety, tolerablity, body distribution and efficacy of [90Y]Y-PentixaTher therapy in CNS lymphoma patients. Recruiting

2024-512097-98-00 Central nervous system (CNS) lymphoma; recurrent or ref 9 2023-11-07
Intratumoral Flu Vaccine and Pembrolizumab in Colorectal Cancer Recruiting

2023-503228-17-00 Colorectal Cancer 4 2023-11-06